Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis

• Published in: Journal of ethnopharmacology 2020-07, Vol.257, p.112789-112789, Article 112789
• Main Authors: Wang, Xiao-wan, Tian, Rui-min, Yang, Yi-qi, Wang, Kai, Li, En-nian, Han, Xiao-dong, Bao, Kun, Mao, Wei, Xu, Hong-tao, Liu, Bo, Xu, Peng
• Format: Article
• Language: English
• Subjects: Adriamycin; Animals; Apoptosis; Apoptosis Regulatory Proteins - metabolism; Caspase 3 - metabolism; Doxorubicin - pharmacology; Glycosides - pharmacology; Intracellular Signaling Peptides and Proteins - metabolism; Kidney - pathology; Lipids - blood; Male; Medicine, Chinese Traditional; Membrane Proteins - metabolism; Nephrotic syndrome; Nephrotic Syndrome - drug therapy; Nephrotic Syndrome - metabolism; Nephrotic Syndrome - pathology; Podocytes - pathology; Proteinuria - drug therapy; Rats; Rats, Sprague-Dawley; Tripterygium; Tripterygium glycoside fraction n2; Tripterygium glycosides
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2020.112789

Tripterygium wilfordii Hook F. (TwHF), a traditional Chinese herb medicine, has been widely used for clinical treatment of various rheumatic immune diseases. Tripterygium glycosides (TG) extracted from TwHF has been verified to process multiple bioactivities, including immunosuppressive, anti-inflammatory and anti-cancer effects. However, the clinical application of TG is limited due to its severe toxicity and narrow therapeutic window. For the clinical safety of TG usage, attenuation of toxicity is the key issue to be solved. Tripterygium glycoside fraction n2 (TG-n2) is a detoxified mixture obtained from TG using a new preparation method. In our previous study, we have demonstrated that TG-n2 has a lower toxicity than TG. The aim of the present study was to screen the renal protective effect of TG-n2 in nephrotic syndrome (NS) induced by adriamycin (ADR) in rats and its effect on apoptosis, as well as the effective difference between TG-n2 and TG. The ADR-induced NS rat model was established. Rats were intravenously injected with ADR (6 mg/kg), then treated with either TG-n2 (10 mg/kg/day) or TG (10 mg/kg/day) by oral gavage for 4 weeks. Clinical indexes in each group were determined. HE staining and electron microscopic analysis were used to evaluate renal histopathological damage. Caspase-3 activity reagent and TUNEL staining were used to estimate renal apoptosis. Protein levels of caspase-3, caspase-9, caspase-8, caspase-12, Bax, Bcl-2, p53, TNF-R1, FLIP and podocin were measured by Western Blot. TG-n2 and TG intervention ameliorated renal function as assessed by the levels of 24-h proteinuria, Cr, BUN, TC, TG, ALB and LDL-c. TG-n2 and TG alleviated the decrease of podocin protein expression and morphological injury of podocyte as screened by Western Blot and electron microscopic analysis. Besides, renal tubular injury was reduced as inspected by light microscopic analysis. TG-n2 and TG could significantly inhibit the apoptosis and activity of caspase-3 in kidney tissues as examined by fluorescence microscopic analysis and reagent. After intervention of TG-n2 and TG, protein levels of cleaved caspase-3, cleaved caspase-8, cleaved caspase-9, Bax, p53 and TNF-R1 in renal issues were significantly decreased compared with ADR group. In contrast, protein level of Bcl-2 was elevated remarkedly. Our data suggested that attenuated TG-n2 may have a similar protective effect with TG in ADR-induced NS in rats by inhibiting activation of apoptosis. [Display omitt